Medications for attention‐deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance

AIM: To assess label compliance in prescription of medications approved for treatment of attention‐deficit/hyperactivity disorder (ADHD) in Japan at the time of this study: methylphenidate (MPH), atomoxetine, and guanfacine. METHODS: Retrospective descriptive study was conducted in prevalent‐user co...

Descripción completa

Detalles Bibliográficos
Autores principales: Fife, Daniel, Voss, Erica A., Hardin, Jill, Rofael, Hany, Solomon, Ira D., Ryan, Patrick B., Stang, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411317/
https://www.ncbi.nlm.nih.gov/pubmed/34180161
http://dx.doi.org/10.1002/npr2.12191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411317/
https://www.ncbi.nlm.nih.gov/pubmed/34180161
http://dx.doi.org/10.1002/npr2.12191

Ejemplares similares